FAMU Receives $13.7 Million Grant from RCMI
TALLAHASSEE – Florida A&M University (FAMU) has been awarded $13.7 million in grants for five-years of support through the Research Center in Minority Institutions (RCMI) Program from the National Institutes of Health’s (NIH) National Institute on Minority Health and Health Disparities (NIMHD).
"The RCMI program at FAMU is designed to strengthen and expand biomedical research and research infrastructure in a major way,” said Ken Redda, professor of medicinal chemistry and interim vice president for research. “Kudos is to Dr. Karam Soliman, Dr. Carl Goodman and their terrific team in generating this significant research funding from the National Institute on Minority Health and Health Disparities. It is a bright day at FAMU."
The RCMI grant award for the period of 2013-2018 will support drug discovery and research aimed at better understanding the makeup and risks associated with various degenerative diseases and their treatment. The grant also will support projects in drug discovery, molecular genetics and biotechnology research. In the area of drug discovery, the grant will aid in developing new drugs that can be used for the treatment of neurodegenerative diseases such as Parkinson’s; stroke; cancer (breast, prostate and lung); and emerging infectious diseases to uncover targets for therapy and translational research.
Download Original Press Release